Skip to search formSkip to main contentSkip to account menu

Remicade

Known as: Remicade [brand name] 
brand name of infliximab a drug used to treat autoimmune disorders
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

infliximab
infliximab 100 MG Injection [Remicade]infliximab Injection [Remicade]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
2016
2016
CT-P13 (Inflectra™, Remsima™) monitoring in patients with inflammatory bowel disease.
2016
2016
Celltrion's infliximab copy shows path to biosimilars in US
2012
2012
Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients
Abstract Objectives: To evaluate the utilization patterns of the anti-tumor necrosis factor (anti-TNF) agents Humira (adalimumab… 
2010
2010
Melatonin Rhythms in Patients With Cirrhosis
To the Editor: We read with interest the recent letter by Cordoba et al. (1), who reported on the apparent normalization of the… 
Review
2009
Review
2009
Treatment of choice for acute severe steroid-refractory ulcerative colitis is remicade.
U lcerative colitis (UC) is usually a lifelong chronic disease with remissions and exacerbations. A severe attack, a potentially… 
Review
2006
Review
2006
Infliximab (Remicade®): from bench to clinical practice. A paradigm shift in rheumatology practice
Infliximab (Remicade®) is a chimeric monoclonal antibody that binds tumour necrosis factor–alpha (TNF-α) and inhibits its… 
2005
2005
Anti-TNF-α therapy for uveitis: Behçet and beyond
In this issue, Benitez-del-Castillo et al1 report six patients with refractory posterior uveitis (five Behcet and one sarcoidosis… 
2003
2003
Verdachtsfälle schwerwiegender Nebenwirkungen nach Infliximab (Remicade®) aus Deutschland
ZUSAMMENFASSUNGHintergrund: Remicade® ist ein chimärer, human-muriner, monoklonaler Antikörper. Remicade® wurde im August 1999… 
1999
1999
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group.
The chimeric anti-TNF antibody Remicade (Infliximab) has recently been approved for human use by the FDA and is now available on… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)